ClinicalTrials.Veeva

Menu

Effect of Probiotic Bacteria on Oral Candida in Frail Elderly

University of Copenhagen logo

University of Copenhagen

Status

Completed

Conditions

Candidiasis

Treatments

Dietary Supplement: L. reuteri DSM 17938/ATCC PTA
Dietary Supplement: Placebo

Study type

Interventional

Funder types

Other

Identifiers

NCT02391532
2010/618

Details and patient eligibility

About

The aim of this study is to investigate the effect of daily intake of the probiotic Lactobacillus Reuteri on the prevalence and counts of oral Candida in frail elderly living in nursery homes.

Full description

The aim of the present study was to investigate the effect of a twice daily intake of lozenges containing probiotic Lactobacillus reuteri on the prevalence and counts of oral Candida in senior residents living in nursery homes. The material consists of 215 elderly persons (range 60 to 102 years) living in 20 different nursery homes in the County of Kronoberg, situated in the southern parts of Sweden. The subjects were consecutively enrolled after informed consent consisting of verbal and written information directed to the individual as well as to their relatives. The study employed a double-blind randomized placebo-controlled design.

Enrollment

215 patients

Sex

All

Ages

60+ years old

Volunteers

Accepts Healthy Volunteers

Inclusion criteria

  • non-smoking
  • ability to cooperate with a dental examination and saliva sampling

Exclusion criteria

  • severe chronic disease, malignancies or ongoing medication with immunosuppressive drugs
  • severe dementia or cognitive impairment

Trial design

Primary purpose

Prevention

Allocation

Randomized

Interventional model

Parallel Assignment

Masking

Triple Blind

215 participants in 2 patient groups, including a placebo group

L. reuteri DSM 17938/ATCC PTA
Active Comparator group
Description:
L. reuteri DSM 17938/ATCC PTA lozenges twice daily for 12 weeks
Treatment:
Dietary Supplement: L. reuteri DSM 17938/ATCC PTA
Placebo
Placebo Comparator group
Description:
Placebo lozenges twice daily for 12 weeks
Treatment:
Dietary Supplement: Placebo

Trial contacts and locations

0

Loading...

Data sourced from clinicaltrials.gov

Clinical trials

Find clinical trialsTrials by location
© Copyright 2026 Veeva Systems